Methods and compositions for modulating telomerase reverse transcriptase (TERT) expression
Patent Number: 6686159
Date of First Priority Issue: Friday September 1st, 2000
Date Issued: Tuesday February 3rd, 2004
Assignee: Sierra Sciences, Inc. (Reno, NV)
Inventors: Andrews, William H. (Reno, NV); Foster, Christopher A. (Carmichael, CA); Fraser, Stephanie (Sparks, NV); Mohammadpour, Hamid (Reno, NV)
From Class: Expansion
Comments: No comments
Telomerase induces cellular escape from sensence and is important for stem cell activity, as well as for cancer to becoming immortal. In this patent agents are identified that suppress the suppressor of telomerase, therapy allowing various types of cells to express telomerase and thereby escape senescence.
View this patent on the USPTO website.
Added to StemCellPatents.com on Monday October 16th, 2006
Social & Bookmarking:
Add Comment
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.